GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » 3-Year Revenue Growth Rate

Zhejiang Conba Pharmaceutical Co (SHSE:600572) 3-Year Revenue Growth Rate : 1.00% (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Conba Pharmaceutical Co 3-Year Revenue Growth Rate?

Zhejiang Conba Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥0.57.

During the past 12 months, Zhejiang Conba Pharmaceutical Co's average Revenue per Share Growth Rate was -0.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Zhejiang Conba Pharmaceutical Co was 24.40% per year. The lowest was -2.70% per year. And the median was 7.10% per year.


Competitive Comparison of Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.


;
;

Zhejiang Conba Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Zhejiang Conba Pharmaceutical Co  (SHSE:600572) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Zhejiang Conba Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Conba Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Conba Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.
Executives
Hu Ji Qiang Director
Yuan Zhen Xian senior management
Yin Shi Shui Supervisors
Xu Chun Ling senior management
Jin Zu Cheng Directors, senior managers
Ye Jian Feng Supervisors
Ying Chun Xiao Director
Chen Ming Director
Luo Guo Liang Director
Wu Zhong Shi Supervisors
Wang Ru Wei Director
Yang Jun De senior management
Yang Xian Min senior management
Chen Yue Zhong senior management
Li Jian Zhong Supervisors

Zhejiang Conba Pharmaceutical Co Headlines

No Headlines